About BioPlus Interphex
BioPlus Interphex Korea 2025 (BIX 2025) unites the entire biopharmaceutical value chain in one venue – including early-stage research and development, advanced manufacturing, logistics, digital health, and more.
BIioPlus Interphex 2025 – Dates, Venue & Location
Dates: 15–17 October 2025 (Wednesday–Friday)
Venue: COEX Hall C (3F) and Conference Room, Seoul, South Korea
Meet with Upperton Pharma Solutions
We are experts in oral solids, nasal and pulmonary dosage forms, able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
From pre-clinical to market, all in one place
Our flexibility and science-led approach saves time, reduces risk and provides pathways from
early-phase clinical studies to commercialisation with confidence.
One team, from start to finish
We keep the knowledge of your molecule within the same project team, ensuring continuity and access to subject matter expertise across all layers of our business.
One site, to accelerate through phases
We accelerate your molecule through clinical phases without transfer delays, with one integrated facility across R&D, GMP and QC, located in Nottingham, UK.
One destination, with a trusted track record
Our regulatory record ensures you’re in good hands to progress your drug development pipeline with quality, speed and confidence.
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.
Meet our team of experts
Ian Lafferty
Chief Technical Officer
Michael Mellor-Clark
Chief Commercial Officer
Request a meeting
Connect with our experts and request a meeting to learn more about our integrated CDMO services.